Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM: Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders (The British Journal of Psychiatry (2018) (1-3) DOI: 10.1192/bjp.2018.24)

DSpace/Manakin Repository

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM: Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders (The British Journal of Psychiatry (2018) (1-3) DOI: 10.1192/bjp.2018.24)
 
Oviedo-Salcedo, Tatiana; de Witte, Lot; Kümpfel, Tania; Kahn, René S; Falkai, Peter; Eichhorn, Peter; Luykx, Jurjen; Hasan, Alkomiet
(2018) British Journal of Psychiatry, volume 213, issue 3, pp.
(Comment)
Abstract
In the reference list, number 11 is stated incorrectly. The correct reference for 11 is: Dyalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology 2011; 10(1):63-74. The authors regret the error.
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Journal Article, Psychiatry and Mental health, Published Erratum, Journal Article
DOI: https://doi.org/10.1192/bjp.2018.77
ISSN: 0007-1250
Publisher: Royal College of Psychiatrists
(Non peer reviewed)